Intercalated combination of chemotherapy and erlotinib for stage IIIA non-small-cell lung cancer: a multicenter, open-label, single-arm, phase II study

OBJECTIVE: This multicenter, open-label, single-arm, phase II trial evaluated the efficacy and safety of an intercalated combination of erlotinib and gemcitabine/cisplatin or carboplatin in patients with stage IIIA non-small-cell lung cancer (NSCLC). REGISTRATION: This trial is registered with Clini...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Zhiwei, Shen, Shengping, Shi, Wenbo, Jiang, Gening, Wang, Xin, Jian, Hong, Zhou, Zhen, Ding, Zhengping, Lu, Shun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636178/
https://www.ncbi.nlm.nih.gov/pubmed/31372055
http://dx.doi.org/10.2147/CMAR.S189287

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6636178/
https://www.ncbi.nlm.nih.gov/pubmed/31372055
http://dx.doi.org/10.2147/CMAR.S189287

Ejemplares similares